Septerna (SEPN) Total Non-Current Liabilities (2023 - 2026)

Septerna (SEPN) recorded quarterly Total Non-Current Liabilities of $191.1 million in Q1 2026, down 10.8% quarter-over-quarter from $214.3 million in Q4 2025, and up 466.7% on a YoY basis from $33.7 million in Q1 2025.

Septerna (SEPN) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends

Septerna's Total Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $191.1 million for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities rose 466.7% year-over-year to $191.1 million; the TTM figure through Mar 2026 stood at $191.1 million (up 466.7% YoY), while the FY2025 annual figure was $214.3 million, up 487.43% from the prior year.
  • Total Non-Current Liabilities was $191.1 million for Q1 2026 at Septerna, down from $214.3 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $217.9 million in Q3 2025 to a low of $19.5 million in Q4 2023.
  • Historically, Total Non-Current Liabilities has averaged $98.5 million across 4 years, with a median of $37.5 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities jumped 87.24% in 2024, then jumped 487.43% in 2025.
  • A 4-year view of Total Non-Current Liabilities shows it stood at $19.5 million in 2023, then soared by 87.24% to $36.5 million in 2024, then surged by 487.43% to $214.3 million in 2025, then slipped by 10.8% to $191.1 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $191.1 million (Q1 2026), $214.3 million (Q4 2025), and $217.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Septerna 1.62 Bn 1.62 Bn - 191.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 191.13 Mn
Dec 31, 2025 214.26 Mn
Sep 30, 2025 217.92 Mn
Jun 30, 2025 37.67 Mn
Mar 31, 2025 33.73 Mn
Dec 31, 2024 36.47 Mn
Sep 30, 2024 37.34 Mn
Dec 31, 2023 19.48 Mn